BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1713612)

  • 21. In situ hybridization histochemical and immunohistochemical evidence that striatal projection neurons co-containing substance P and enkephalin are overrepresented in the striosomal compartment of striatum in rats.
    Wang HB; Deng YP; Reiner A
    Neurosci Lett; 2007 Oct; 425(3):195-9. PubMed ID: 17868995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of neuropeptide mRNA expression in intrastriatal striatal transplants by host dopaminergic afferents.
    Campbell K; Wictorin K; Björklund A
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10489-93. PubMed ID: 1438238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-related loss of mRNA encoding adenosine A2 receptor in the rat striatum.
    Schiffmann SN; Vanderhaeghen JJ
    Neurosci Lett; 1993 Aug; 158(2):121-4. PubMed ID: 8233082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-cell RT-PCR, in situ hybridization histochemical, and immunohistochemical studies of substance P and enkephalin co-occurrence in striatal projection neurons in rats.
    Wang HB; Laverghetta AV; Foehring R; Deng YP; Sun Z; Yamamoto K; Lei WL; Jiao Y; Reiner A
    J Chem Neuroanat; 2006 Apr; 31(3):178-99. PubMed ID: 16513318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny neurons.
    Yan Z; Flores-Hernandez J; Surmeier DJ
    Neuroscience; 2001; 103(4):1017-24. PubMed ID: 11301208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of adenosine receptors selectively activates gene expression in striatal enkephalinergic neurons.
    Karcz-Kubicha M; Ferré S; Díaz-Ruiz O; Quiroz-Molina C; Goldberg SR; Hope BT; Morales M
    Neuropsychopharmacology; 2006 Oct; 31(10):2173-9. PubMed ID: 16452987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cloned G protein-coupled protein with a distribution restricted to striatal medium-sized neurons. Possible relationship with D1 dopamine receptor.
    Schiffmann SN; Libert F; Vassart G; Dumont JE; Vanderhaeghen JJ
    Brain Res; 1990 Jun; 519(1-2):333-7. PubMed ID: 2168785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study.
    Albin RL; Qin Y; Young AB; Penney JB; Chesselet MF
    Ann Neurol; 1991 Oct; 30(4):542-9. PubMed ID: 1838677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-methyl-D-aspartate receptor antagonism alters substance P and met5-enkephalin biosynthesis in neurons of the rat striatum.
    Somers DL; Beckstead RM
    J Pharmacol Exp Ther; 1992 Aug; 262(2):823-33. PubMed ID: 1380083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-methyl-D-aspartate acutely increases proenkephalin mRNA in the rat striatum.
    Beckstead RM
    Synapse; 1995 Dec; 21(4):342-7. PubMed ID: 8869164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The muscarinic toxin 3 augments neuropeptide mRNA in rat striatum in vivo.
    Wang JQ; Jolkkonen M; McGinty JF
    Eur J Pharmacol; 1997 Sep; 334(1):43-7. PubMed ID: 9346326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene.
    Le Moine C; Normand E; Bloch B
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4205-9. PubMed ID: 1827915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haloperidol increases proenkephalin mRNA levels in the caudate-putamen of the rat: a quantitative study at the cellular level using in situ hybridization.
    Romano GJ; Shivers BD; Harlan RE; Howells RD; Pfaff DW
    Brain Res; 1987 Apr; 388(1):33-41. PubMed ID: 3580841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutamatergic regulation of striatal peptide gene expression in rats.
    Jolkkonen J; Jenner P; Marsden CD
    J Neural Transm Park Dis Dement Sect; 1995; 10(2-3):187-98. PubMed ID: 9620062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of cholinergic and peptidergic development in the rat striatum in culture.
    Kessler JA
    Dev Biol; 1986 Jan; 113(1):77-89. PubMed ID: 2417902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneous distribution of dopamine D2 receptor mRNA in the rat striatum: a quantitative analysis with in situ hybridization histochemistry.
    Szele FG; Artymyshyn R; Molinoff PB; Chesselet MF
    Anat Rec; 1991 Dec; 231(4):548-58. PubMed ID: 1838906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study.
    Augood SJ; Faull RL; Love DR; Emson PC
    Neuroscience; 1996 Jun; 72(4):1023-36. PubMed ID: 8735227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular mRNA expression of the transcription factor NGFI-B suggests a gene regulatory role in striatal opiate-peptide neurons.
    Bäckman C; Hoffer BJ; Misawa H; Morales M
    Brain Res; 2001 Jun; 903(1-2):26-32. PubMed ID: 11382384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of adenosine A2 receptor mRNA in the human brain.
    Schiffmann SN; Libert F; Vassart G; Vanderhaeghen JJ
    Neurosci Lett; 1991 Sep; 130(2):177-81. PubMed ID: 1795877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ontogeny of gene expression of adenosine A2 receptor in the striatum: early localization in the patch compartment.
    Schiffmann SN; Vanderhaeghen JJ
    J Comp Neurol; 1992 Mar; 317(2):117-28. PubMed ID: 1573059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.